This image provided by Pfizer shows its COVID-19 pills. Drugmaker Pfizer said Tuesday, Nov. 16, 2021, it is submitting its experimental pill for U.S. authorization, setting the stage for a likely launch in coming weeks. (Pfizer via AP)

Pfizer, US ink $5.29B deal for possible COVID-19 treatment

November 18, 2021 by admin

This image provided by Pfizer shows its COVID-19 pills. Drugmaker Pfizer said Tuesday, Nov. 16, 2021, it is submitting its experimental pill for … Read more

$5.29b

Pfizer, US ink $5.29B deal for possible COVID-19 treatment

Kenneth Walker III sparks Seahawks in second half as Seattle pulls away to beat Carolina 37-27 – Winnipeg Free Press

Bonner and Allen lead Connecticut over New York 78-63 to open the WNBA semifinal series – Winnipeg Free Press

Armenian PM, Azerbaijan Prez to Meet in Spain Next Month, Talks to Include Macron & Scholz